Surmodics has announced that it has acquired the business of Alta Biomed, a medical device coating and testing services company specialising in surface technologies for vascular and other medical devices.
The acquisition is a strategic addition to Surmodics’ growing portfolio of haemocompatible and biocompatible surface technologies, the company says in a press release, bringing Alta Biomed’s proprietary PzF thin-film surface modification technology to Surmodics’ portfolio.
“As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address increasingly complex blood-contacting applications,” said Charlie Olson, president, Surmodics Coatings, Biomaterials and Catheter Technologies. “PzF gives our customers another proven thin-film surface modification to consider as they develop the next generation of devices.”
PzF is an ultra-thin polymer surface modification technology designed to enhance haemocompatibility for blood and tissue-contacting medical devices and materials.
The technology can be applied to a variety of substrates ranging from metals, polymers, medical fabrics and tissue. Device applications include stents, grafts, catheters, filters, nitinol devices, ePTFE devices and PET/polyester materials.
